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With the technical development of ultrasonography (US), electromagnetic tracking-based fusion 
imaging of real-time US and computed tomography/magnetic resonance (CT/MR) images has 
been used for percutaneous hepatic intervention such as biopsy and radiofrequency ablation 
(RFA). Because of the fusion imaging technique, the fused CT or MR images show the same 
plane and move synchronously while performing real-time US. With this information, fusion 
imaging can enhance lesion detectability and reduce the false positive detection of focal hepatic 
lesions with poor sonographic conspicuity. Three-dimensional US can also be fused with real-
time US for the percutaneous RFA of liver tumors requiring overlapping ablation. When fusion 
imaging is not sufficient for identifying small focal hepatic lesions, contrast-enhanced US can be 
added to fusion imaging.
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Introduction
Ultrasonography (US) has been widely used for interventional procedures for the liver due to a 
number of advantages: real-time capability, no radiation hazard, easy accessibility, and low cost [1,2]. 
When performing US-guided interventional procedures, the operators need to mentally register the 
reference data set (computed tomography [CT] or magnetic resonance [MR] images) and the working 
data set (real-time US images) [3]. However, this mental registration can be challenging when the 
liver cannot be scanned with orthogonal transverse, sagittal, or coronal planes, which are frequently 
used for the interpretation of CT or MR images in our daily practice. In addition, the deformation 
and displacement of the liver occurs by the breathing motion and heartbeats of patients. Moreover, 
a sonographic window of the liver is sometimes limited by the rib cage, colon, or omental fat 
surrounding the liver. Therefore, if erroneous mental registration occurs, this may lead to mistargeting 
during US-guided hepatic interventions [4]. 
Fusion imaging is a technique that fuses two different imaging modalities. In the field of hepatic 
intervention, real-time US is usually fused with other imaging modalities such as CT, MR, and 
positron emission tomography (PET)/CT. In our daily practice, challenging small target lesions are 
more frequently detected than before due to recent advances in CT and MR technology. Therefore, Min Woo Lee
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fusion imaging has gained considerable attention since it can help 
operators conduct interventional procedures with high confidence 
and accuracy for challenging target lesions [5,6]. In this article, an 
electromagnetic (EM) tracking-based fusion imaging technique 
and its current clinical application for the hepatic intervention is 
reviewed.
Electromagnetic Tracking-Based Image Fusion
For the fusion imaging technique, a variety of tracking methods 
are available, including optical, image-based, and EM tracking [3]. 
In general, optical tracking is most commonly utilized for surgical 
procedures and image-based tracking for vascular interventions. 
In contrast, EM tracking is most widely used for US-guided hepatic 
interventions. There are three components of the EM tracking-based 
fusion imaging technique: the magnetic field generator, position 
sensor, and position sensor unit. The magnetic field generator, 
which is located near the patient, creates a magnetic field, thereby 
inducing currents in the position sensor, which is mounted on the US 
transducer. As the US probe moves, the magnitude of the electrical 
current in the position sensor changes with respect to the magnetic 
field. With this information, the position sensor unit installed in the 
US machine calculates the exact location of the position sensor and 
thus, determines the direction and position of the US transducer 
[3,7]. This enables the side-by-side or overlay display of real-time US 
images and fused CT or MR images.
Image fusion by EM tracking can be performed by using either 
external fiducial markers or internal anatomic landmarks. When CT 
is performed with external fiducial markers attached to the body 
surface around a target organ, image fusion can be performed 
automatically between real-time US images and CT images. This is 
because the fiducial markers contain position sensor coils and are 
radio-opaque on CT images [8]. External MRI fiducial markers would 
also be helpful for accurate image fusion between real-time US and 
MR images. However, they are under development and are rarely 
available for EM tracking-based fusion imaging. 
Image fusion can also be performed using the internal markers 
of patients. Internal markers refer to anatomic landmarks within a 
patient’s liver, such as focal hepatic lesions (i.e., cyst or calcification), 
bifurcation of the hepatic or portal vein, or liver configuration 
[9]. Despite several differences among various vendors, the basic 
concept of image fusion using internal markers is similar. The first 
step of image fusion using this method is uploading the data set to 
be fused with real-time US to the US machine. Then, image fusion is 
performed, which generally consists of plane and point registration. 
Plane registration is a process of finding the same plane on real-
time US and uploaded CT or MR images. Any plane that clearly 
shows anatomic landmarks on both data sets can be used for plane 
registration. After plane registration, point registration is performed 
to match the two image data sets more accurately. This is usually 
performed by pointing out the same anatomic point near the target 
lesion between real-time US and CT or MR images, which can be 
repeated until optimal image fusion is obtained (Fig. 1). If a target 
lesion is already identified on real-time US before applying fusion 
imaging, image fusion can be performed very quickly using the 
following method: the image plane containing the target lesion is 
used for plane registration, and the target lesion itself is used for 
point registration by indicating the center of the lesion.
Instead of repeated point registrations, other vendors have a 
“rotate” or “drag” function to match the real-time US and uploaded 
CT or MR images, which is usually performed on the overlay display 
of the two data sets. There is also manual image fusion, which is 
performed by matching three internal markers on any image plane, 
including the oblique plane.
After the application of the fusion imaging technique, real-time 
US and fused CT or MR images appear side-by-side or overlaid on 
the US monitor. Therefore, the fused CT or MR image shows the 
same plane and moves synchronously with real-time US (Video clip 
1). With the information of the fused CT or MR images, the location 
of the target lesion in relation to the perilesional anatomic landmark 
is easier to recognize on real-time US. Therefore, fusion imaging 
allows operators to detect a target lesion with poor sonographic 
conspicuity.
The time required for image fusion varies depending on the fusion 
imaging technologies and the level of experience of the operators. 
Since image fusion using internal markers may be cumbersome for 
beginners, automatic image fusion between real-time US and pre-
procedural CT or MR images would be helpful to simplify the overall 
workflow. Although prototype automatic image fusion by sweeping 
the liver volume has been introduced [10], clinical data for hepatic 
intervention with this automatic registration are rarely available. 
However, automatic registration is expected to be helpful for less 
experienced operators with respect to manual registration [11,12].
According to ex vivo experimental studies [13,14], the registration 
error between real-time US and CT images was within 3 mm, and 
the targeting error was also about 3 mm. Although these studies 
were performed in the explanted liver, the error seems to be 
acceptable.
Liver Application of Fusion Imaging
Many hepatic interventional procedures benefit from fusion 
imaging, enabling operators to conduct percutaneous interventional 
procedures for challenging target lesions that would otherwise Fusion imaging of US and CT/MRI for hepatic intervention
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A B
Fig. 1. The process of image fusion between real-time 
ultrasonography (US) and magnetic resonance (MR) images by 
using internal markers.
A. Uploaded MR data are processed in the US machine and are 
displayed in the coronal plane (right figure) in the US monitor. The 
US image (left figure) is also scanned along the coronal plane that 
shows similar anatomic structures. Arrowheads indicate the right 
hepatic vein, and this vein was used as the anatomic landmark 
for plane registration. B. For the calibration of image fusion, point 
registration is performed by placing the cursor (cross marker) at 
the same anatomic structure. In this example, the bifurcation point 
of the inferior vena cava and the right hepatic vein was used for 
point registration. C. After plane and point registrations, the target 
lesion usually appears at a similar location of each image. Then, 
point registration is added by placing the cursor at the center (cross 
marker) of the tumor.
C
Fig. 2. Fusion imaging-guided biopsy of a focal hepatic lesion with poor sonographic conspicuity in a patient with pancreatic head 
cancer.
A. Hepatobiliary-phase magnetic resonance (MR) image shows a 6-mm focal hepatic lesion (arrow) in the liver. B. Percutaneous biopsy was 
performed to rule out metastasis. The lesion (arrow) can be identified with the use of fusion imaging even though it was invisible on B-mode 
ultrasonography. Biopsy revealed that it was a metastasis from pancreatic cancer.
A BMin Woo Lee
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not be possible [5,6,9,15-22]. For example, fusion imaging is 
useful for the percutaneous biopsy of a focal hepatic lesion that 
has poor conspicuity on B-mode US [6,23,24] (Figs. 2, 3). Using 
this technique, we can reduce the sampling error by an accurate 
localization of the target lesions.
Fusion imaging also improves the conspicuity of hepatocellular 
carcinomas (HCCs) and the feasibility of percutaneous radio-
frequency ablation (RFA) of HCCs not identifiable on B-mode US 
[9,18]. Therefore, it can reduce the number of RFA sessions for HCCs 
invisible on B-mode US [18]. Given that the detectability of HCCs 
depends on the tumor size [1,25], fusion imaging is likely to be more 
useful for small HCCs. This assumption was supported by a recent 
study where the detectability of HCCs smaller than 2 cm was much 
higher when using fusion imaging than when using conventional 
B-mode US, whereas for HCCs equal to or larger than 2 cm, this 
was not the case [5]. Fusion imaging is also useful in avoiding the 
mistargeting of HCC-ablating a pseudolesion, not the true lesion-by 
reducing the false-positive detection of small HCCs on B-mode US 
[5,22] (Fig. 4). Fusion imaging can also guide accurate overlapping 
ablations of HCCs on the basis of the fused CT or MR images (Fig. 5).
A B
Fig. 3. Fusion imaging-guided biopsy of a focal hepatic lesion in a patient with hepatitis B virus carrier.
A. Precontrast T1-weighted magnetic resonance (MR) image shows an ill-defined lesion (arrow) with an iso-to-high signal intensity. B. 
The lesion (arrow) shows arterial enhancement. C. In the hepatobiliary phase, the lesion (arrow) shows a low signal intensity. D. Planning 
ultrasonography (US) for radiofrequency ablation (RFA) was performed since the lesion was diagnosed as a small hepatocellular carcinoma 
(HCC) on the MR images. On planning US with fusion imaging, the location (arrow) of the lesion on US was different from that on the fused 
MR image. In addition, since the signal intensity on the pre-contrast T1-weighted image was not consistent with that of the usual HCC, 
instead of RFA, percutaneous biopsy was performed; it revealed that the lesion was an eosinophilic abscess.
C DFusion imaging of US and CT/MRI for hepatic intervention
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However, not all small HCCs are visible on fusion imaging. 
The detection of small HCCs in a deep location in patients with 
liver cirrhosis is still challenging even with the guidance of fusion 
imaging. According to a recent study [9], out of 120 HCCs (mean 
tumor size, 1.0 cm; range, 0.5 to 2.2 cm), 82 HCCs (68.3%)  were 
invisible even on fusion imaging. However, 31.7% (26/82) of the 
HCCs unidentifiable on fusion imaging could be ablated by inserting 
an electrode on the basis of peritumoral anatomic landmarks.
Fusion Imaging with Contrast-Enhanced US
Since contrast-enhanced ultrasonography (CEUS) is also useful 
for the guidance of percutaneous hepatic interventions [26-28], 
CEUS can be used in addition to fusion imaging if the target lesions 
have poor conspicuity even on fusion imaging (Figs. 6-8). When 
used simultaneously, CEUS is displayed with fusion imaging, not 
with B-mode US [29]. Among various US contrast agents, Sonazoid 
(perflubutane microbubbles; GE Healthcare, Oslo, Norway), offering 
both vascular and post-vascular phases, is effective in localizing 
A B
Fig. 4. Fusion imaging-guided radiofrequency ablation (RFA) of a 1.2-cm hepatocellular carcinoma (HCC) with poor sonographic 
conspicuity in a patient with a hepatitis B virus carrier.
A. Arterial-phase T1-weighted magnetic resonance (MR) image shows a small enhancing tumor (arrow) in the right liver dome. B. On 
planning ultrasonography (US) before image fusion, a small echogenic lesion (arrow) was identified and was considered to be the HCC 
identified upon MRI. C. However, after image fusion, the index tumor (arrow) was located at a different site. Therefore, the lesion identified 
before image fusion was a pseudolesion. Percutaneous RFA was performed with confidence. D. Immediate post-RFA computed tomography 
scan shows that it was a technical success with a sufficient ablative margin (arrowheads). In this case, mistargeting was avoided by using 
the fusion imaging technique.
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small HCCs that have poor conspicuity on B-mode US [30,31].
The combined use of fusion imaging and CEUS has several 
advantages for localizing small HCCs with poor sonographic 
conspicuity. Most of all, the overall procedure time of CEUS-guided 
intervention can be reduced. With fusion imaging, the operator 
can estimate the location of the target lesion before contrast 
injection, making it easier to evaluate a nodule throughout the 
vascular phase. If the lesion shows arterial enhancement and a low 
echogenic defect during the postvascular phase, we do not have to 
re-inject Sonazoid to see the so-called defect-reperfusion imaging 
A B
C D
Fig. 5. Fusion imaging-guided radiofrequency ablation (RFA) of a 
3.1-cm hepatocellular carcinoma.
A. Arterial-phase T1-weighted magnetic resonance (MR) image 
shows an enhancing tumor (arrow) in the right lobe of the liver. B. 
The lesion (arrow) shows a low signal intensity in the hepatobiliary 
phase. C. Fusion imaging-guided RFA was performed. Residual 
unablated tumor (arrow) was identified intuitively on the basis 
of the fused MR images. D. The residual tumor was ablated by 
repositioning one electrode. A large echogenic zone (arrowheads) 
was made, which was sufficiently large to cover the entire tumor. E. 
Immediate post-RFA computed tomography scan shows that it was 
a technical success with a sufficient ablative margin (arrowheads).
EFusion imaging of US and CT/MRI for hepatic intervention
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Fig. 6. Fusion imaging and contrast-enhanced ultrasonography (US)-
guided radiofrequency ablation (RFA) of a 1-cm hepatocellular 
carcinoma (HCC) in a patient with a hepatitis B virus carrier.
A. Arterial-phase T1-weighted magnetic resonance (MR) image shows a 
subtle enhancing lesion (arrow) in segment 6 of the liver. B. The lesion 
(arrow) shows a low signal intensity in the hepatobiliary phase. C. Fusion 
imaging-guided RFA was performed. Due to the coarse echo texture of the 
liver, the index tumor was unidentifiable even on the US of fusion imaging 
where the tumor (arrow) was located in the fused MR image. D. Contrast-
enhanced US was added to the fusion imaging. In the arterial phase, an 
enhancing nodule (arrow) is identified. E. In the Kupffer phase, the lesion 
(arrow) is seen as a defect, confirming that the lesion is an HCC. F. Targeting 
was performed in the Kupffer phase. Arrowheads indicate the exposed tip 
of an electrode. G. Immediate post-RFA computed tomography scan shows 
that the tumor was completely covered by the ablation zone (arrowheads), 
suggestive of technical success.
GMin Woo Lee
234   Ultrasonography 33(4), October 2014  e-ultrasonography.org
Fig. 7. Fusion imaging and contrast-enhanced ultrasonography (US)-guided radiofrequency ablation (RFA) of a subcentimeter-
sized recurrent hepatocellular carcinoma (HCC) in a patient with a hepatitis B virus carrier. The patient had previously undergone 
percutaneous RFA of HCC.
A. In the magnetic resonance (MR) images (arterial phase, followed by portal phase, T2-weighted image, diffusion-weighted image, and 
hepatobiliary phase), the lesion (arrowheads) shows the typical imaging features of HCC. Although the size of the lesion was measured to 
0.8 cm, it was regarded as a recurrent HCC since it was a new lesion, not seen in the previous computed tomography or MR images. B. To be 
certain, contrast-enhanced US was performed in addition to the fusion imaging. On the scout image, the lesion (arrow) was identified at the 
same location where the index tumor (arrow) was located on the fused MR image. C. In the arterial phase, the lesion (arrow) shows strong 
enhancement. D. In the Kupffer phase, the lesion (arrow) is seen as a defect, indicating that the lesion is an HCC. E. Immediate post-RFA 
computed tomography scan shows that the tumor was completely covered by the ablation zone (arrow), suggestive of technical success. 
D E
A
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Fig. 8. Fusion imaging and contrast-enhanced ultrasonography 
(CEUS)-guided radiofrequency ablation (RFA) of a 1.3-cm 
hepatocellular carcinoma (HCC) in a patient with a hepatitis B 
virus carrier. 
A. Arterial-phase T1-weighted magnetic resonance (MR) image 
shows a small enhancing lesion (arrow) in the periphery of segment 
6 of the liver. B. The lesion (arrow) shows a low signal intensity 
in the hepatobiliary phase. C. Fusion imaging-guided RFA was 
performed. On the US of the fusion imaging, a small low echoic 
lesion (arrow) was identified at the similar location (arrow) of the 
tumor on the fused MR image. D. However, to obviate the risk of 
mistargeting, CEUS was performed additionally. On CEUS, the lesion 
identified on fusion imaging (C) did not show arterial enhancement. 
True HCC was obscured by a rib shadow and was identified as a 
small enhancing lesion when the patient breathed in slightly when 
the liver was slightly shifting down (not shown here, Video clip 3). 
The lesion was targeted with the patient holding the breath after 
inhaling a small amount of air in the Kupffer phase when the index 
tumor (arrow) was seen as a defect. The arrowheads indicate the 
exposed tip of the electrode. E. Immediate post-RFA computed 
tomography scan shows that the tumor was completely covered by 
the ablation zone (arrowheads), suggestive of technical success. 
In this example, mistargeting was avoided by the use of CEUS in 
addition to fusion imaging.
EMin Woo Lee
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for HCC [32]. Therefore, the overall procedure time of CEUS-guided 
intervention would be substantially decreased if CEUS is combined 
with fusion imaging [33].
Image Fusion with 3-Dimensional US Images
Three-dimensional (3D) US can also be used as a reference data 
set and can be fused with real-time US. Unlike CT or MR images, 
which are obtained prior to the RFA procedure, 3D US images are 
obtained at the time of RFA procedures after electrode insertion. 
If 3D US is fused with real-time US, it can help the operator to 
monitor and control RFA procedures. On the basis of the fused 3D 
US, the operator can understand comprehensive 3D relationships of 
the index tumor, peritumoral anatomic landmarks, and electrodes 
inserted through the tumor. The information with respect to the 
location of the electrode in relation to the tumor makes electrode 
repositioning more convenient whenever it is needed (Video clip 2).
Electromagnetic Needle Tracking
Virtual needle tracking can be provided by the fusion imaging 
system with the use of the EM position sensor embedded in the 
distal tip of a needle or attached to the hilt of the needle [34,35]. 
Theoretically, the accuracy of virtual needle tracking depends on the 
location of the EM position sensor. A needle with a position sensor 
at the distal tip of the needle can provide a more accurate expected 
electrode path than that with a position sensor attached to the hilt 
of the needle because the needle can bend in the liver at the time 
of targeting [34,36]. This fact was supported by a study in which the 
virtual tracking error was less than 2 mm when the position sensor 
was located at the distal tip of the needle [34]. A virtual needle 
tracking system would be valuable for interventional procedures for 
challenging target lesions. For example, target lesions that cannot 
be reached by the usual in-plane approach would benefit from 
a needle tracking system that can allow operators to reach the 
target lesion with an out-of-plane approach [36,37]. In addition, 
large tumors requiring overlapping ablation would benefit from the 
needle tracking system since the virtual electrode tip appears within 
an echogenic cloud during the ablation procedures [35].
Limitation of Fusion Imaging
Since the usual reference data sets (CT, MRI, or PET/CT) are obta-
ined with the patients in a breath-holding state, they contain 
static images. In comparison, a working data set (real-time US) is 
affected by tissue deformation due to the patient’s respiration and 
movement. In addition, the positioning of patients during a real-
time US examination can differ from that during the acquisition 
of reference data sets. Moreover, most commercially available 
fusion imaging systems are based on rigid registration, which 
lacks compensating patient respiration and movement [7]. Hence, 
some degree of registration error is inevitable between real-time 
US and fused reference data sets. This assumption is supported by 
the results of a previous study [38] in which the mean maximum 
registration error between real-time US and fused CT images was 
11.5 mm in patients with hepatic metastasis. To decrease the 
registration error, it would be better to perform image fusion when 
the respiratory status of a patient is the same as when the reference 
data set was acquired. For example, if the MR images to be fused 
with real-time US was obtained during the expiratory phase, image 
fusion should be performed during the same expiratory state of the 
patient.
In a recent study [39], mistargeting occurred in 1.3% (7/551) 
of the patients with HCCs even though fusion imaging was used 
for the guidance of RFA of HCCs. All patients who suffered from 
mistargeting were hepatitis B virus (HBV) carriers, and their tumors 
were mostly smaller than 1.5 cm and were located in the periphery 
of the liver. Given that liver cirrhosis caused by HBV is characterized 
by macronodular cirrhosis, which has numerous pseudolesions 
mimicking the target tumor on the US examination [4], caution 
should be taken during RFA procedures in patients who are HBV 
carriers. In addition, when the tumor is located in the periphery of 
the liver, it may not be possible to use large vessels as anatomic 
landmarks to locate the tumor. Moreover, liver deformation and 
displacement by the patient’s breathing motion may be more 
apparent in the peripheral than in the central liver [39]. Therefore, 
for these challenging cases with a small size and a peripheral 
location, CEUS can be combined with fusion imaging to obviate the 
risk of mistargeting (Fig. 8, Video clip 3). 
In the EM tracking-based fusion imaging technique, increased 
magnetic field strength can increase the accuracy of image fusion. 
Hence, the magnetic field generator should be located near the 
region of interest and skin fiducials, which may restrict free device 
movement during the procedures. In addition, since magnetic field 
homogeneity is also crucial, any conductive object or magnetic 
substance should be located far away so as not to alter the 
magnetic field [3,40]. 
Future of Fusion Imaging
Since the manual fusion of real-time US and CT or MR images 
is difficult for beginners, most vendors are developing automatic 
image fusion methods. However, they need more improvements. 
First of all, the speed of image fusion and its accuracy should be Fusion imaging of US and CT/MRI for hepatic intervention
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improved further. In addition, the success rate of automatic image 
fusion should be enhanced. Furthermore, although automatic image 
fusion between real-time US and preprocedural CT images has been 
introduced by some vendors, it should also work with preprocedural 
MR images. In general, MR images are preferred as the reference 
data set over CT images due to the high contrast between the target 
lesions and the surrounding anatomic landmarks [22,41].
To overcome the limitations of EM tracking-based fusion imaging, 
respiratory gating or motion correction by the dynamic reference 
position sensor placed on the patient would be helpful in minimizing 
the registration error due to the movement of the patient or of the 
devices [3]. In addition, we hope that real-time non-rigid registration 
that can provide localized stretching and deformation of the fused 
CT or MR images [42] and thus, expected to compensate for liver 
deformation occurring on real-time US, will be available in the near 
future.
Summary
Fusion imaging is a technique that fuses the working data set and 
the reference data sets. With the fused reference data sets, fusion 
imaging is useful for localizing inconspicuous focal hepatic lesions 
on B-mode US. It can facilitate accurate interventional procedures 
such as RFA and biopsy even for challenging target lesions.
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Supplementary Material
Video clip 1. Fusion imaging of real-time ultrasonography (US) and 
magnetic resonance (MR) images. After applying fusion imaging, 
real-time US and fused computed tomography (CT) or MR images 
are displayed simultaneously. Therefore, while we are performing 
real-time US, the fused CT or MR image shows the same plane and 
moves synchronously (http://dx.doi.org/10.14366/usg.14021.v001). 
Video clip 2. Fusion with 3-dimensional (3D) ultrasonography 
(US)-guided radiofrequency ablation. Due to the subphrenic location 
of the tumor, artificial ascites was introduced into the abdominal 
cavity. After the insertion of three electrodes into the tumor, 3D 
US was obtained by scanning the liver in a sweeping manner with 
the patients in a breath-holding state. The 3D US volume data was 
fused with real-time 2D US, and the two image sets were displayed 
simultaneously on a split-screen display. In the video clip obtained 
during ablation, it can be seen that the ablative margin seems to be 
sufficient (http://dx.doi.org/10.14366/usg.14021.v002).
Video clip 3. Contrast-enhanced ultrasonography (CEUS) combined 
with fusion imaging for radiofrequency ablation. On CEUS, arterial 
enhancement is noted at a different site, the slightly upper side of 
the low echoic lesion, which was considered to be the index tumor 
on fusion imaging before contrast injection. Therefore, mistargeting 
was avoided owing to CEUS (http://dx.doi.org/10.14366/usg.14021.
v003).
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